Cagri (10 vials) Next Gen Peptides CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Identification and utility exploration of a highly potent and long acting bullfrog GLP 1 analogue in GLP 1 and amylin combination therapy ScienceDirect Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica